Keyphrases
Muscle-invasive Bladder Cancer
57%
Hypoxia
55%
Radiotherapy
53%
Molecular Radiotherapy
38%
Radionuclides
38%
Hypoxia Detection
37%
Bladder Cancer
34%
Prostate Cancer
33%
Tumor
29%
Cas9 Protein
27%
Chemotherapy
27%
Immune Response
27%
Genomic Studies
27%
Gene Expression
27%
Immune Effect
27%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
27%
BC2001
27%
Novel Therapeutic Targets
27%
Radionuclide Therapy
27%
Gene Abnormality
27%
Biomarkers of Response
27%
Randomized Controlled Trial
27%
Cancer Xenograft
27%
Oxygen-enhanced Magnetic Resonance Imaging
27%
Predictive Biomarker
27%
Xenograft
27%
Hypoxia Signature
27%
Multiple Gene Expression
27%
Cetuximab
27%
Resistant Cells
27%
Binding Inhibition
27%
Breast Tumor Cells
27%
Cell Affinity
27%
Lutetium-177 (177Lu)
27%
EGFR-targeting
27%
TaqMan Low-density Array
19%
Hypoxic Zone
18%
Pimonidazole
18%
Biomarker Discovery
18%
Dynamic Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
18%
Copyright
17%
NanoString
15%
Cancer Research
14%
Radiation Therapy
13%
Springer Nature
12%
Tumor Heterogeneity
11%
Transcriptomic Data
11%
Hypoxic Tumors
11%
External Beam Radiotherapy
11%
Immune-suppressive
11%
Medicine and Dentistry
Biological Marker
100%
Hypoxia
83%
Radiation Therapy
61%
Neoplasm
56%
Muscle Invasive Bladder Cancer
46%
Bladder Cancer
41%
Gene Expression
37%
Prostate Cancer
37%
Androgen Deprivation Therapy
27%
Randomized Controlled Trial
27%
Chemotherapy
27%
Tumor Xenograft
27%
Magnetic Resonance Imaging
27%
Radioisotope
27%
Radiation Therapy
27%
Growth Inhibition
27%
Tumor Cell
27%
Gold Nanoparticle
27%
Cetuximab
27%
Lutetium 177
27%
Transcriptomics
21%
Xenograft
16%
Cas9
13%
Clustered Regularly Interspaced Short Palindromic Repeat
13%
Linear Energy Transfer
13%
Radiosensitivity
12%
Dynamic Contrast-Enhanced MRI
11%
Pimonidazole
11%
Cancer Cell
10%
Tumor Hypoxia
10%
Biopsy Technique
10%
Cancer Research
9%
External Beam Radiotherapy
8%
Overall Survival
8%
Brachytherapy
7%
Distant Metastasis Free Survival
7%
Biochemical Recurrence Free Survival
7%
Tumor Suppressor Protein
6%
Tumor Initiation
6%
Cell Cycle
6%
Tumor Resistance
6%
Survival Rate
6%
Drug Resistance
6%
Cancer Therapy
6%
Personalized Medicine
6%
Tumor Progression
6%
Metastatic Carcinoma
6%
Malignant Neoplasm
6%
Oncogene
6%
Transcriptome
5%